4.8 Article

A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy

Christian Labenz et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)

Review Pharmacology & Pharmacy

Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology

Roger F. Butterworth

DRUGS (2019)

Review Gastroenterology & Hepatology

Thrombocytopenia in chronic liver disease

Markus Peck-Radosavljevic

LIVER INTERNATIONAL (2017)

Article Gastroenterology & Hepatology

The Animal Naming Test: An Easy Tool for the Assessment of Hepatic Encephalopathy

Francesca Campagna et al.

HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Fasting Blood Ammonia Predicts Risk and Frequency of Hepatic Encephalopathy Episodes in Patients With Cirrhosis

John M. Vierling et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy

Jatinderpal Singh et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Biochemistry & Molecular Biology

Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy

Ana Agusti et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo

Maja Johansson et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)

Article Gastroenterology & Hepatology

GR3027 antagonizes GABAA receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy

Maja Johansson et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)

Article Gastroenterology & Hepatology

Randomized, Double-Blind, Controlled Study of Glycerol Phenylbutyrate in Hepatic Encephalopathy

Don C. Rockey et al.

HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Covert hepatic encephalopathy: Agreement and predictive validity of different indices

Sara Montagnese et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Gastrointestinal dysfunction in liver cirrhosis

Evangelos Kalaitzakis

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Endocrinology & Metabolism

The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy

M. M. Lauridsen et al.

METABOLIC BRAIN DISEASE (2013)

Review Gastroenterology & Hepatology

Abnormal hematological indices in cirrhosis

Amir A. Qamar et al.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients

P Amodio et al.

JOURNAL OF HEPATOLOGY (2001)

Review Gastroenterology & Hepatology

Neuropsychological characterization of hepatic encephalopathy

K Weissenborn et al.

JOURNAL OF HEPATOLOGY (2001)